Fig 1.
Scoring system for the risk of recurrence on the study cohort.
According to Smith et al. [21], the total score (from the age, tumor size and nuclear grade) 0–3 is categorized as low-to-intermediate risk, 4–6 is regarded as high risk.
Table 1.
Baseline characteristics of the study cohort.
Fig 2.
Kaplan Meier plot of cumulative recurrence-free survival among BCS-based regimens.
Abbreviations: BCS, breast-conserving surgery; HT, hormone therapy; RT, radiation therapy; RFS, recurrence-free survival.
Table 2.
Univariate and multivariable adjusted hazard ratios of covariates for breast cancer recurrence.
Fig 3.
Sub-analysis: Kaplan Meier plot of cumulative recurrence-free survival between regimens with and without hormone therapy.
(A) Postmenopausal, (B) Premenopausal. Abbreviations: BCS, breast-conserving surgery; HT, hormone therapy; RT, radiation therapy; RFS, recurrence-free survival.